市场调查报告书
商品编码
1467588
2024-2032 年介入性心臟病学和周边血管器材市场(按产品类型、适应症、年龄层、最终用户和地区划分)Interventional Cardiology and Peripheral Vascular Devices Market by Product Type, Indication, Age Group, End User, and Region 2024-2032 |
2023年,IMARC Group介入性心臟病学和周边血管器械市场规模达250亿美元。 。患有慢性心臟病的人数不断增加,週边动脉疾病(PAD)发病率激增,以及消费者对微创(MI)手术的偏好不断上升,是推动市场发展的一些关键因素。
介入性心臟病学是指心臟病学的次专业,依靠血管内导管技术和透视技术来治疗多种瓣膜疾病、冠状动脉疾病和先天性心臟病。另一方面,週边血管装置是用于治疗动脉阻塞和血管狭窄的医疗装置,特别是在周边脉管系统中,导致流向身体不同部位的血流减少。这些介入方法通常用于治疗影响循环系统的心臟病和周围血管疾病,以避免併发症和疤痕,同时最大限度地减少疼痛并促进更快的康復。因此,介入性心臟病学和周边血管装置在治疗各种结构性心臟病和动脉相关疾病以及週边血管内和冠状动脉手术中得到了广泛的应用。
患有冠状动脉疾病 (CAD) 等慢性心臟病的人数不断增加,更加需要早期发现和干预,以防止致命后果。再加上週边动脉疾病(PAD)发生率的上升,是推动市场成长的主要因素。此外,患者和医疗保健专业人员从传统手术转向微创 (MI) 手术,因为微创手术切口较小、手术疼痛、损伤和疤痕更少、住院时间更短、准确性更高且恢復更快。与此一致的是,不断增长的老年人口正在加剧全球心臟病和血管疾病的负担,这反过来又增加了产品需求。此外,由于技术的快速进步,领先的製造商正在开发新型介入性心臟病学和周边血管设备的创新变体,以获得更好的治疗效果。同时,主要参与者不断推出产品和不断增加的产品批准数量推动了市场成长。其他因素,包括生物可吸收支架的引入、急诊和重症监护入院病例的增加、有利的报销政策、改善医疗基础设施以及持续的研发(R&D)活动,也为市场增长提供了积极的推动力。
The global interventional cardiology and peripheral vascular devices market size reached US$ 25.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 47.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.07% during 2024-2032. The increasing number of individuals suffering from chronic heart conditions, surging incidences of peripheral arterial disease (PAD), and rising consumer preferences for minimally invasive (MI) procedures represent some of the key factors driving the market.
Interventional cardiology refers to the sub-specialty of cardiology that relies on intravascular catheter-based techniques with fluoroscopy to treat numerous valvular, coronary artery, and congenital heart diseases. On the other hand, peripheral vascular devices are medical devices used for treating artery blockages and narrowing of blood vessels, especially in the peripheral vasculature, resulting in reduced blood flow to different body parts. These interventional methods are commonly employed for managing cardiology diseases and peripheral vascular disorders affecting the circulatory system to avoid complications and scars while minimizing pain and promoting faster recovery. As a result, interventional cardiology and peripheral vascular devices find extensive applications in the treatment of various structural heart diseases and artery-related ailments, as well as in peripheral endovascular and coronary procedures.
The increasing number of individuals suffering from chronic heart conditions, such as coronary artery diseases (CADs), has strengthened the need for early detection and intervention to prevent fatal consequences. This, coupled with the rising incidences of peripheral arterial disease (PAD), represents the primary factor driving the market growth. Additionally, there has been a substantial shift from traditional surgeries toward minimally invasive (MI) procedures among patients and healthcare professionals as they involve smaller incisions, less surgical pain, injury, and scarring, shorter hospital stays, higher accuracy, and quick recovery. In line with this, the expanding geriatric population is contributing to the growing burden of cardiological and vascular diseases across the globe, which in turn has augmented the product demand. Furthermore, due to rapid technological advancements, the leading manufacturers are developing new and innovative variants of interventional cardiology and peripheral vascular devices for better treatment outcomes. Along with this, continuous product launches by key players and the increasing number of product approvals have propelled market growth. Other factors, including the introduction of bio-absorbable stents, rising admission cases in emergency and critical care, favorable reimbursement policies, improving healthcare infrastructure, and ongoing research and development (R&D) activities, are also providing a positive thrust to the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global interventional cardiology and peripheral vascular devices market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, indication, age group, and end user.
Inferior Vena Cava (IVC) Filters
Plaque Modification Devices
Hemodynamic Flow Alteration Devices
Accessories
Angioplasty Balloons
Angioplasty Stents
Angioplasty Catheters
Endovascular Aneurysm Repair Stent Grafts
The report has provided a detailed breakup and analysis of the interventional cardiology and peripheral vascular devices market based on the product type. This includes inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, accessories, angioplasty balloons, angioplasty stents, angioplasty catheters, and endovascular aneurysm repair stent grafts. According to the report, angioplasty balloons represented the largest segment.
Coronary Intervention
Peripheral Arterial Disease
A detailed breakup and analysis of the interventional cardiology and peripheral vascular devices market based on the indication has also been provided in the report. This includes coronary intervention and peripheral arterial disease.
Geriatric
Adults
Paediatric
The report has provided a detailed breakup and analysis of the interventional cardiology and peripheral vascular devices market based on the age group. This includes geriatric, adults, and paediatric. According to the report, geriatric represented the largest segment.
Hospitals
Ambulatory Surgical Centers
Others
The report has provided a detailed breakup and analysis of the interventional cardiology and peripheral vascular devices market based on the end user. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals represented the largest segment.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for interventional cardiology and peripheral vascular devices. Some of the factors driving the North America interventional cardiology and peripheral vascular devices market included its rapidly aging population, the presence of a large patient pool, increasing healthcare expenditure, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global interventional cardiology and peripheral vascular devices market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, B. Braun Melsungen AG, Becton Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Group Incorporated, Cordis Corporation, Koninklijke Philips N.V., Medtronic plc., Teleflex Incorporated, Terumo Corporation, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.